At a Glance
Therapeutic Area:
Approved Applications:
Lexiscan® is a pharmacologic stress agent (PSA) for radionuclide myocardial perfusion imaging (MPI). This agent temporarily increases blood flow through the coronary arteries and is increasingly used by an aging “at risk” population who cannot exercise, but needs to mimic the increase in coronary blood flow in order to undergo radionuclide myocardial perfusion imaging (MPI) for the detection of coronary artery disease.
Applications In Development:
Acquisition Date:
March 2011
Royalty Seller:

© 2014 Royalty Pharma, RP Management LLC. All Rights Reserved.